aytu, innovus

AYTU (ATYU) ‘Team’ Letter on Innovus (INNV) Acquisition.

Aytu Team: I’m pleased to share with you some exciting, transformational news about Aytu BioScience that we announced publicly...
Steven Boyd, Armistice Capital, Biotech Stock Review

Armistice Capital Voting on AYTU (AYTU) and Innovus (INNV) Merger.

13D Filing on AYTU (As of the date hereof, each of the Reporting Persons may be deemed to be the beneficial owner...

Internet Stock Review Initiates Coverage On HealthLynked Corp. (HLYK) $0.23.

NAPLES, Fla., Oct. 04, 2017 (GLOBE NEWSWIRE) -- HealthLynked Corp. (HLYK) today announced it has retained Institutional Analyst Inc., to provide coverage...
Dyadic

Investor Presentation Slides From Dyadic (DYA) $6.40.

Really, How Do We Do It? Live Short Term Chart
Dyadic, Biotech Stock Review

Dyadic (DYAI) $7.00 Called a ‘Gamechanger’ – Gets $14 Price Target.

Highly Respected Wall Street Analyst Jason Kolbert Issues $14.00 Price Target On Dyadic.

Medtech Incubator in Final Stages of Launch.

TrueNature (TNTY) Has Spent the Past Year Gearing Up. News of a Launch and First Incubation Effort Could be Around the Corner...
Mitesco

Healthcare Incubators and Wearable Devices.

Originally published August 22, 2019 The Global Wearable Devices Market is expected to exceed more than $51.50 billion by...

True Nature (TNTY) Readies Launch of Mitesco: “The Medtech Incubator”

ATLANTA, GA, Nov. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- True Nature Holding, Inc. (OTCQB: TNTY, “the Company”) today announced that...
Internet Stock Review

What We’re Watching.

“Biotech, Beverages and Bears - Oh My!” — Daniel K. McMahon
Biotech Stock Review

True Nature (TNTY) Mitesco Set to Launch Mitesco PLC Incubator — Aligns With Matheson...

Hires Legal Powerhouse Matheson as Counsel and Advisor on its European Acquisitions Efforts. Established...

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!